Forza X1, Inc.

$ Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000173112223001400 Filed on August 08, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$15.34M	$16.52M	$258.4K
YoY Change	10.0%	6292.01%
Cash & Equivalents	$5.439M	$16.52M	$258.4K
Short-Term Investments	$9.897M
Other Short-Term Assets	$130.0K	$158.8K	$33.27K
YoY Change	-70.9%	377.34%
Inventory	$777.8K	$522.0K	$16.83K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$16.24M	$17.20M	$308.5K
YoY Change	12.9%	5474.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.052M	$998.0K	$378.4K
YoY Change	66.64%	163.75%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$10.00K	$7.520K
YoY Change
Other Assets			$247.1K
YoY Change
Total Long-Term Assets	$1.157M	$1.125M	$625.5K
YoY Change	83.23%	79.78%
TOTAL ASSETS
Total Short-Term Assets	$16.24M	$17.20M	$308.5K
Total Long-Term Assets	$1.157M	$1.125M	$625.5K
Total Assets	$17.40M	$18.32M	$934.0K
YoY Change	15.85%	1861.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$38.51K	$79.12K	$5.442K
YoY Change	-2.46%	1353.84%
Accrued Expenses	$73.90K	$111.5K	$41.52K
YoY Change	532.15%	168.63%
Deferred Revenue		$5.800K
YoY Change
Short-Term Debt	$0.00	$104.0K	$11.16K
YoY Change	-100.0%	832.26%
Long-Term Debt Due	$20.00K	$17.02K
YoY Change
Total Short-Term Liabilities	$226.4K	$406.9K	$58.13K
YoY Change	14.77%	599.94%
LONG-TERM LIABILITIES
Long-Term Debt	$60.00K	$67.72K	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$23.07K
YoY Change
Total Long-Term Liabilities	$63.33K	$90.79K	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$226.4K	$406.9K	$58.13K
Total Long-Term Liabilities	$63.33K	$90.79K	$0.00
Total Liabilities	$289.7K	$497.7K	$58.13K
YoY Change	46.88%	756.12%
SHAREHOLDERS EQUITY
Retained Earnings	-$8.623M	-$7.576M	-$1.624M
YoY Change	223.34%	366.49%
Common Stock	$15.78K	$15.78K	$7.000K
YoY Change	51.04%	125.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$17.11M	$17.82M	$875.9K
YoY Change
Total Liabilities & Shareholders Equity	$17.40M	$18.32M	$934.0K
YoY Change	15.85%	1861.62%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Revenues Revenues		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001901305
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2022Q4	us-gaap	Inventory Net InventoryNet		usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent		usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Revenues Revenues		usd
CY2022Q2	us-gaap	Revenues Revenues		usd
	us-gaap	Revenues Revenues		usd
CY2023Q2	us-gaap	Interest And Other Income InterestAndOtherIncome		usd
	us-gaap	Interest And Other Income InterestAndOtherIncome		usd
CY2022Q2	us-gaap	Dividend Income Operating DividendIncomeOperating		usd
	us-gaap	Dividend Income Operating DividendIncomeOperating		usd
CY2023Q2	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	FRZA	Change Of Rightofuse Asset ChangeOfRightofuseAsset		usd
	FRZA	Gain Loss On Disposition Of Asset GainLossOnDispositionOfAsset		usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability		usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent		usd
	FRZA	Payment Of Equipment Financing PaymentOfEquipmentFinancing		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber		shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2021Q4	FRZA	Fair Value Of Option Outstanding FairValueOfOptionOutstanding		usd
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue
CY2022	FRZA	Fair Value Of Option Forfeited FairValueOfOptionForfeited		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	FRZA	Fair Value Of Option Granted FairValueOfOptionGranted		usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	FRZA	Fair Value Of Option Forfeited FairValueOfOptionForfeited		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41469
	dei	Entity Registrant Name EntityRegistrantName	FORZA X1, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-3159685
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3101 S. US-1
	dei	Entity Address City Or Town EntityAddressCityOrTown	Ft. Pierce
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	34982
	dei	City Area Code CityAreaCode	(772)
	dei	Local Phone Number LocalPhoneNumber	429-2525
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	FRZA
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15784000	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16516320	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12767199	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	521960	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	158808	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	519735	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	17197088	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	13286934	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	119036	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	162069	usd
CY2023Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	7517	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	7517	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	997973	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	765406	usd
CY2023Q2	us-gaap	Assets Assets	18321614	usd
CY2022Q4	us-gaap	Assets Assets	14221926	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	79118	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	99028	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	111544	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	92767	usd
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	17019	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	89349	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	86245	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5800	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5300	usd
CY2023Q2	FRZA	Due To Affiliates Current DueToAffiliatesCurrent	104043	usd
CY2022Q4	FRZA	Due To Affiliates Current DueToAffiliatesCurrent	169851	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	406873	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	453191	usd
CY2023Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	67720	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	23072	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	68532	usd
CY2023Q2	us-gaap	Liabilities Liabilities	497665	usd
CY2022Q4	us-gaap	Liabilities Liabilities	521723	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15784000	shares
CY2023Q2	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	15784000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10450000	shares
CY2022Q4	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	10450000	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	15784	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	10450	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	25384583	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	17777385	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7576418	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4087632	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	17823949	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13700203	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18321614	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14221926	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	40796	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	13012	usd
	us-gaap	Cost Of Revenue CostOfRevenue	90737	usd
	us-gaap	Cost Of Revenue CostOfRevenue	24090	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	-40796	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	-13012	usd
	us-gaap	Gross Profit GrossProfit	-90737	usd
	us-gaap	Gross Profit GrossProfit	-24090	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	334315	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	63941	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	688977	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	141806	usd
CY2023Q2	us-gaap	Salaries And Wages SalariesAndWages	864838	usd
CY2022Q2	us-gaap	Salaries And Wages SalariesAndWages	296863	usd
	us-gaap	Salaries And Wages SalariesAndWages	1727602	usd
	us-gaap	Salaries And Wages SalariesAndWages	479149	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	261473	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	218769	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	964121	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	434439	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	69867	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	16532	usd
	us-gaap	Professional Fees ProfessionalFees	193907	usd
	us-gaap	Professional Fees ProfessionalFees	35610	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	48230	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	11335	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	83926	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	19072	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	1578723	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	607440	usd
	us-gaap	Operating Expenses OperatingExpenses	3658533	usd
	us-gaap	Operating Expenses OperatingExpenses	1110076	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1619519	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-620452	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3749270	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1134166	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	1493	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	257	usd
	us-gaap	Interest Expense InterestExpense	1784	usd
	us-gaap	Interest Expense InterestExpense	858	usd
CY2022Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	8	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	31	usd
CY2023Q2	us-gaap	Dividend Income Operating DividendIncomeOperating	137358	usd
	us-gaap	Dividend Income Operating DividendIncomeOperating	262268	usd
CY2022Q2	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-31582	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-31582	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	135865	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-31831	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	260484	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-32409	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1483654	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-652283	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3488786	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1166575	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1483654	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-652283	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3488786	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1166575	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11446391	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11446391	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7000000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10950863	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10950863	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7000000	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1542449	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-514292	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1028157	usd
CY2022Q2	us-gaap	Proceeds From Partnership Contribution ProceedsFromPartnershipContribution	500000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-652283	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	875874	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13700203	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	341163	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-2005132	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	12036234	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6929552	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	341817	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-1483654	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	17823949	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3488786	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1166575	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	83926	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	14267	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	682980	usd
	FRZA	Change Of Rightofuse Asset ChangeOfRightofuseAsset	43033	usd
	FRZA	Gain Loss On Disposition Of Asset GainLossOnDispositionOfAsset	31582	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	521960	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	16831	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-360927	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-55206	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-19910	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-7891	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	18777	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	6396	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	500	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-42356	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2882869	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1083846	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	224088	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	188666	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-224088	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-188666	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6996015	usd
	FRZA	Repayment Of Deferred Offering Costs RepaymentOfDeferredOfferingCosts	66463	usd
	FRZA	Repayment Of Deferred Offering Costs RepaymentOfDeferredOfferingCosts	141629	usd
	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	500000	usd
	FRZA	Payment Of Equipment Financing PaymentOfEquipmentFinancing	7666	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	409505	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	750596	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	343697	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	119843	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6856078	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-272382	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	3749121	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1544894	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12767199	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1803285	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16516320	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	258391	usd
	us-gaap	Interest Paid Net InterestPaidNet	1784	usd
	us-gaap	Interest Paid Net InterestPaidNet	858	usd
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	92405	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_zuyTfMjG9TYg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86F_zNC6ODAzEQra">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States “U.S. GAAP” requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. Included in those estimates are assumptions about useful life of fixed assets. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16516320	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12767199	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zVQhP2QoUGN4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_862_ztUk6IMwPHha">Concentrations of Credit and Business Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company minimizes the concentration of credit risk associated with its cash by maintaining its cash with high quality federally insured financial institutions. However, cash balances in excess of the Federal Deposit Insurance Corporation (“FDIC”) insured limit of $<span id="xdx_903_ecustom--FdicInsuredLimit_c20230630_pp0p0" title="FDIC insured limit">250,000</span> are at risk. As of June 30, 2023 and December 31, 2022, the Company had $<span id="xdx_903_eus-gaap--CashFDICInsuredAmount_c20230630_pp0p0" title="FDIC excess amount">16,205,328</span> and $<span id="xdx_90E_eus-gaap--CashFDICInsuredAmount_c20221231_pp0p0" title="FDIC excess amount">12,446,216</span>, respectively, in excess of FDIC insured limits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q2	FRZA	Fdic Insured Limit FdicInsuredLimit	250000	usd
CY2023Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	16205328	usd
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	12446216	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1130410	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	813917	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	132437	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	48511	usd
CY2023Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	997973	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	765406	usd
	us-gaap	Depreciation Depreciation	83926	usd
	us-gaap	Depreciation Depreciation	19072	usd
CY2022	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	0.0033
CY2022Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P2Y
CY2022Q4	us-gaap	Payments For Rent PaymentsForRent	7517	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	7517	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	119036	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	162069	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	89349	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	86245	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	23072	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	68532	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	112421	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	154777	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	45777	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	69680	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	115456	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3035	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	112421	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.04	pure
CY2023Q2	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P1Y2M15D
	us-gaap	Operating Lease Cost OperatingLeaseCost	45100	usd
	us-gaap	Lease Cost LeaseCost	45100	usd
CY2023Q1	FRZA	Net Asset Value NetAssetValue	43579	usd
CY2023Q1	us-gaap	Lessee Finance Lease Term Of Contract1 LesseeFinanceLeaseTermOfContract1	P60M
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.075	pure
CY2023Q1	FRZA	Net Asset Value NetAssetValue	48826	usd
CY2023Q1	us-gaap	Lessee Finance Lease Term Of Contract1 LesseeFinanceLeaseTermOfContract1	P60M
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.03	pure
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	17019	usd
CY2023Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	67720	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	10475	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	20950	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	20950	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	20950	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	20945	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	874	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	95144	usd
CY2023Q2	FRZA	Finance Lease Imputed Interest FinanceLeaseImputedInterest	10405	usd
CY2023Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	84739	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	409505	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	750596	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	343697	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	119843	usd
CY2023Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	79731	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	56581	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	31813	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	36186	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	111544	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	92767	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16516320	usd
CY2023Q2	FRZA	Working Capital WorkingCapital	16790215	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12767199	usd
CY2022Q4	FRZA	Working Capital WorkingCapital	12833743	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3488786	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1166575	usd
	us-gaap	Short Term Lease Payments ShortTermLeasePayments	2200	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	11000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	0	usd
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	172500	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	6.25
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	306705	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.88
	FRZA	Warrant Activity WarrantActivity	0	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	682980	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.11	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.15	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0298	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0362	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1441500	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.41
CY2022	FRZA	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2	P10Y
CY2022	FRZA	Fair Value Of Option Granted FairValueOfOptionGranted	4009913	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1441500	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.41
	FRZA	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Option Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionWeightedAverageRemainingContractualTerm2	P0Y25D
CY2022Q4	FRZA	Fair Value Of Option Outstanding FairValueOfOptionOutstanding	4009913	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	36944	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue	1.33
	FRZA	Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeited Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm2	P9Y8M26D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1404556	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.46
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P9Y3M7D
CY2023Q2	FRZA	Fair Value Of Option Outstanding FairValueOfOptionOutstanding	4009913	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	360125	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.98
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P9Y2M19D

Files In Submission

Name	View Source	Status
0001731122-23-001400-index-headers.html	Edgar Link	pending
0001731122-23-001400-index.html	Edgar Link	pending
0001731122-23-001400.txt	Edgar Link	pending
0001731122-23-001400-xbrl.zip	Edgar Link	pending
e4908_10q.htm	Edgar Link	pending
e4908_ex31-1.htm	Edgar Link	pending
e4908_ex31-2.htm	Edgar Link	pending
e4908_ex32-1.htm	Edgar Link	pending
e4908_ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
frza-20230630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
frza-20230630_cal.xml	Edgar Link	unprocessable
frza-20230630_def.xml	Edgar Link	unprocessable
frza-20230630_lab.xml	Edgar Link	unprocessable
frza-20230630_pre.xml	Edgar Link	unprocessable
e4908_10q_htm.xml	Edgar Link	completed
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

Forza X1, Inc.

2023 Q3 Form 10-Q Financial Statement

#000173112223001400 Filed on August 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission